OptiFort Plus
OptiFort Plus, licence 80140732: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- OptiFort
- Licence holder
- Vita Aid Professional Therapeutics
- NPN or DIN-HM
- 80140732
- Status
- Active licence
- Licence date
- 7 May 2025
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine A | 300.0 microgram RAE | Not calculated |
| Vitamine A | 1000.0 UI | Not calculated |
| Vitamine E Source : Acétate de d-alpha-tocophéryle | 10.0 mg AT | Not calculated |
| Vitamine E Source : Acétate de d-alpha-tocophéryle | 15.0 UI | Not calculated |
| Vitamine C Source : Palmitate d'ascorbyle | 10.0 mg | 20,000 µg |
| Zinc Source : Diglycinate de zinc | 5.0 mg | 10,000 µg |
| Ginkgo biloba Source : Ginkgo biloba - feuille Potency : 6.0 % Terpene lactones | Not specified | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Extract : Matériel brut sec Dry plant equivalent : 3000 mg Potency : 24.0 % Flavonoid glycosides | 60.0 mg | Not calculated |
| Vaccinium myrtillus Source : Vaccinium myrtillus - Fruit Potency : 36.0 % Anthocyanins | 80.0 mg | Not calculated |
| Acide hyaluronique Source : Streptococcus equi - capsule extracellulaire bactérienne | 60.0 mg | Not calculated |
| Acide hyaluronique Source : Hyaluronate de sodium | 60.0 mg | Not calculated |
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 50.0 mg | Not calculated |
| Lutéine Source : Tagetes erecta - Oléorésine (herbe en fleurs) | 10.0 mg | Not calculated |
Non-medicinal ingredients
Fibre de Pyrus malus (Pomme), L-Leucine, Pullulane, Hypromellose, Dioxyde de silicium colloïdal
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 ans | 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to improve macular pigment optical density. Helps to maintain eyesight/support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Used in Herbal Medicine to help slow the progression of disorders of the eye, such as diabetic and hypertensive retinopathy, and macular degeneration.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80140732
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.